Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15INK4b normally associated with differentiation

Abstract

Deregulated expression of the proto-oncogene c-myb, which results from provirus integration, is thought to be responsible for transformation in a set of murine leukemia virus (MuLV)-induced myeloid leukemias (MML). We reported recently that this transcription factor promotes proliferation by directly transactivating c-myc and inhibits cell death through its up-regulation of Bcl-2 (Schmidt et al., 2000). To understand more about how these cells become transformed we looked at how they deal with cellular pathways inducing growth arrest. Specifically, we were interested in the expression of the tumor suppressor gene Cdkn2b (p15INK4b) in MML because this gene is expressed during myeloid differentiation and its inactivation by methylation has been shown to be important for the development of human acute myeloid leukemia. mRNA levels for p15INK4b and another INK4 gene p16INK4a were examined in monocytic Myb tumors and were compared with expression of the same genes in c-myc transformed monocytic tumors that do not express c-Myb. The Cdkn2a (p16INK4a) gene was generally not expressed in either tumor type, an observation explained by methylation or deletion in the promoter region. Although Cdkn2b (p15INK4b) mRNA was expressed in the Myc tumors, many transcripts were aberrant in size and contained only exon 1. Surprisingly, in the majority of the Myb tumors there was no p15INK4b transcription and neither deletion nor methylation could explain this result. Additional experiments demonstrated that, in the presence of constitutive c-Myb expression, the induction of p15INK4b mRNA that accompanies differentiation of M1 cells to monocytes does not occur. Therefore, the transcriptional regulator c-Myb appears to prevent activation of a growth arrest pathway that normally accompanies monocyte maturation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 5
Figure 3
Figure 4
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Amanullah A, Hoffman B, Liebermann DA . 2000 Blood 96: 475–482

  • Amanullah A, Liebermann DA, Hoffman B . 2000 Oncogene 19: 2967–2977

  • Badley JE, Bishop GA, St John T, Frelinger JA . 1988 Biotechniques 6: 114–116

  • Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J, Yu AL . 1997 Cancer Res. 57: 832–836

  • Bies J, Hoffman B, Amanullah A, Giese T, Wolff L . 1996 Oncogene 12: 355–363

  • Bies J, Mukhopadhyaya R, Pierce J, Wolff L . 1995 Cell Growth Differ. 6: 59–68

  • Cameron EE, Baylin SB, Herman JG . 1999 Blood 94: 2445–2451

  • Cogswell JP, Cogswell PC, Kuehl WM, Cuddihy AM, Bender TM, Engelke U, Marcu KB, Ting JP . 1993 Mol. Cell Biol. 13: 2858–2869

  • Drexler HG . 1998 Leukemia 12: 845–859

  • Evans JL, Moore TL, Kuehl WM, Bender T, Ting JP . 1990 Mol. Cell Biol. 10: 5747–5752

  • Frampton J, Ramqvist T, Graf T . 1996 Genes Dev. 10: 2720–2731

  • Goda SK, Minton NP . 1995 Nucl. Acids Res. 23: 3357–3358

  • Gunning P, Ponte P, Okayama H, Engel J, Blau H, Kedes L . 1983 Mol. Cell Biol. 3: 787–795

  • Hannon GJ, Beach D . 1994 Nature 371: 257–261

  • Herman JG, Jen J, Merlo A, Baylin SB . 1996 Cancer Res. 56: 722–727

  • Hirama T, Koeffler HP . 1995 Blood 86: 841–854

  • Hogg A, Schirm S, Nakagoshi H, Bartley P, Ishii S, Bishop JM, Gonda TJ . 1997 Oncogene 15: 2885–2898

  • Latres E, Malumbres M, Sotillo R, Martin J, Ortega S, Martin-Caballero J, Flores JM, Cordon-Cardo C, Barbacid M . 2000 EMBO J. 19: 3496–3506

  • Liebermann DA, Hoffman-Liebermann B . 1989 Oncogene 4: 583–592

  • Malumbres M, Perez DC, I, Hernandez MI, Jimenez M, Corral T, Pellicer A . 2000 Mol. Cell Biol. 20: 2915–2925

  • Malumbres M, Perez DC, I, Santos J, Melendez B, Mangues R, Serrano M, Pellicer A, Fernandez-Piqueras J . 1997 Oncogene 14: 1361–1370

  • Nason-Burchenal K, Wolff L . 1993 Proc. Natl. Acad. Sci. USA 90: 1619–1623

  • Oh IH, Reddy EP . 1999 Oncogene 18: 3017–3033

  • Quelle DE, Ashmun RA, Hannon GJ, Rehberger PA, Trono D, Richter KH, Walker C, Beach D, Sherr CJ, Serrano M . 1995 Oncogene 11: 635–645

  • Ragione FD, Iolascon A . 1997 Leuk. Lymphoma 25: 23–35

  • Ratajczak MZ, Perrotti D, Melotti P, Powzaniuk M, Calabretta B, Onodera K, Kregenow DA, Machalinski B, Gewirtz AM . 1998 Blood 91: 1934–1946

  • Schmidt M, Nazarov V, Stevens L, Watson R, Wolff L . 2000 Mol. Cell Biol. 20: 1970–1981

  • Schwaller J, Pabst T, Koeffler HP, Niklaus G, Loetscher P, Fey MF, Tobler A . 1997 Leukemia 11: 54–63

  • Selvakumaran M, Liebermann DA, Hoffman-Liebermann B . 1992 Mol. Cell. Biol. 12: 2493–2500

  • Seoane J, Pouponnot C, Staller P, Schader Eilers M, Massagué J . 2001 Nature Cell Biol. 3: 400–408

  • Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA . 1996 Cell 85: 27–37

  • Shen-Ong GL, Wolff L . 1987 J. Virol. 61: 3721–3725

  • Siebert R, Willers CP, Opalka B . 1996 Leuk. Lymphoma 23: 505–520

  • Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, Karsunky H, Möröy T, Bartek J, Massagué J, Hänel F, Eilers M . 2001 Nature Cell Biol. 3: 392–399

  • Taylor D, Badiani P, Weston K . 1996 Genes Dev. 10: 2732–2744

  • Teofili L, Rutella S, Chiusolo P, La Barbera EO, Rumi C, Ranelletti FO, Maggiano N, Leone G, Larocca LM . 1998 Exp. Hematol. 26: 1133–1139

  • Thompson EB . 1998 Ann. Rev. Physiol. 60: 575–600

  • Weinberg RA . 1997 Cell 88: 573–575

  • Wolff L . 1996 Crit. Rev. Onco. 7: 245–260

  • Wolff L, Koller R, Bies J, Nazarov V, Hoffman B, Amanullah A, Krall M, Mock B . 1996 Curr. Topics Microbiol. Immunol. 211: 191–199

  • Wolff L, Koller R, Davidson W . 1991 J. Virol. 65: 3607–3616

  • Wolff L, Mushinski JF, Shen-Ong GL, Morse III HC . 1988 J. Immunol. 141: 681–689

  • Zhang B, Peng Z . 2000 J. Mol. Biol. 299: 1121–1132

  • Zhang S-L, DuBois W, Ramsay ES, Bliskovski V, Morse III HC, Taddesse-Heath L, Vass WC, DePinho R, Mock BA . 2001 Mol. Cell Biol. 21: 310–318

  • Zobel A, Kalkbrenner F, Vorbrueggen G, Moelling K . 1992 Biochem. Biophys. Res. Commun. 186: 715–722

Download references

Acknowledgements

We thank Douglas Lowy and Beverly Mock for critical reading of the manuscript. We also thank Elizabeth E Cameron and J Mikovits for helpful advice in using the bisulphite genomic sequencing protocol and Frank Ruscetti for providing us with the cell line KG1a. We are grateful to Dan Liebermann and Beverly Mock for kindly providing us with Cdkn2 cDNA probes for p16INK4a and p15INK4b.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Linda Wolff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmidt, M., Koller, R., Haviernik, P. et al. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15INK4b normally associated with differentiation. Oncogene 20, 6205–6214 (2001). https://doi.org/10.1038/sj.onc.1204821

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204821

Keywords

This article is cited by

Search

Quick links